American Century Companies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-287,812
Closed -$43.5M 2650
2022
Q3
$43.5M Buy
287,812
+96,781
+51% +$14.6M 0.04% 420
2022
Q2
$27.8M Sell
191,031
-493,803
-72% -$72M 0.02% 574
2022
Q1
$81.2M Buy
684,834
+494,275
+259% +$58.6M 0.06% 340
2021
Q4
$26.3M Sell
190,559
-88,217
-32% -$12.2M 0.02% 630
2021
Q3
$38.7M Buy
278,776
+91,051
+49% +$12.6M 0.03% 517
2021
Q2
$18.2M Buy
187,725
+1,696
+0.9% +$165K 0.01% 689
2021
Q1
$12.7M Sell
186,029
-2,629
-1% -$180K 0.01% 739
2020
Q4
$16.2M Buy
188,658
+10,591
+6% +$908K 0.01% 666
2020
Q3
$11.6M Buy
178,067
+27,811
+19% +$1.81M 0.01% 680
2020
Q2
$11M Buy
150,256
+74,466
+98% +$5.44M 0.01% 652
2020
Q1
$2.58M Buy
+75,790
New +$2.58M ﹤0.01% 816
2018
Q1
Sell
-57,216
Closed -$1.54M 1405
2017
Q4
$1.54M Buy
57,216
+20,444
+56% +$552K ﹤0.01% 1046
2017
Q3
$1.38M Sell
36,772
-19,618
-35% -$734K ﹤0.01% 1096
2017
Q2
$1.41M Buy
+56,390
New +$1.41M ﹤0.01% 1089